Rajesh Narasimamurthy

Rajesh Narasimamurthy

Auto-generated profile, based on publicly available information

Rajesh Narasimamurthy

Program in Cancer and Stem Cell Biology, Duke–NUS Medical School, Singapore, Singapore

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Science Advances
Verified
Journal Article
Open access
PDF file
DFDinorah Friedmann-Morvinski
Dinorah Friedmann-Morvinski
RNRajesh Narasimamurthy
Rajesh Narasimamurthy
YXYifeng Xia
Yifeng Xia
CMChad Myskiw
Chad Myskiw
YSYasushi Soda
Yasushi Soda
IVInder M. Verma
Inder M. Verma
Glioblastoma multiforme (GBM) is the most common and lethal form of intracranial tumor. We have established a lentivirus-induced mouse model of malignant gliomas, which faithfully captures the pathophysiology and molecular signature of mesenchymal human GBM. RNA-Seq analysis of these tumors revealed high nuclear factor κB (NF-κB) activation showing enrichment of known NF-κB target genes. Inhibition of NF-κB by either depletion of IκB kinase 2 (IKK2), expression of a IκBαM super repressor, or using a NEMO (NF-κB essential modifier)–binding domain (NBD) peptide in tumor-derived cell lines attenuated tumor proliferation and prolonged mouse survival. Timp1, one of the NF-κB target genes significantly up-regulated in GBM, was identified to play a role in tumor proliferation and growth. Inhibition of NF-κB activity or silencing of Timp1 resulted in slower tumor growth in both mouse and human GBM models. Our results suggest that inhibition of NF-κB activity or targeting of inducible NF-κB genes is an attractive therapeutic approach for GBM.

11 February 2020 in eLife
Verified
Journal Article
Open access
JPJonathan M Philpott
Jonathan M Philpott
RNRajesh Narasimamurthy
Rajesh Narasimamurthy
CRClarisse G Ricci
Clarisse G Ricci
AFAlfred M Freeberg
Alfred M Freeberg
SHSabrina R Hunt
Sabrina R Hunt
CPCarrie L Partch
Carrie L Partch
Post-translational control of PERIOD stability by Casein Kinase 1δ and ε (CK1) plays a key regulatory role in metazoan circadian rhythms. Despite the deep evolutionary conservation of CK1 in eukaryotes, little is known about its regulation and the factors that influence substrate selectivity on functionally antagonistic sites in PERIOD that directly control circadian period. Here we describe a molecular switch involving a highly conserved anion binding site in CK1. This switch controls conformation of the kinase activation loop and determines which sites on mammalian PER2 are preferentially phosphorylated, thereby directly regulating PER2 stability. Integrated experimental and computational studies shed light on the allosteric linkage between two anion binding sites that dynamically regulate kinase activity. We show that period-altering kinase mutations from humans to Drosophila differentially modulate this activation loop switch to elicit predictable changes in PER2 stability, providing a foundation to understand and further manipulate CK1 regulation of circadian rhythms.

30 April 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
SMShusaku Masuda
Shusaku Masuda
RNRajesh Narasimamurthy
Rajesh Narasimamurthy
HYHikari Yoshitane
Hikari Yoshitane
JKJae Kyoung Kim
Jae Kyoung Kim
YFYoshitaka Fukada
Yoshitaka Fukada
DVDavid M. Virshup
David M. Virshup
Casein kinase 1 (CK1) plays a central role in regulating the period of the circadian clock. In mammals, PER2 protein abundance is regulated by CK1-mediated phosphorylation and proteasomal degradation. On the other hand, recent studies have questioned whether the degradation of the core circadian machinery is a critical step in clock regulation. Prior cell-based studies found that CK1 phosphorylation of PER2 at Ser478 recruits the ubiquitin E3 ligase β-TrCP, leading to PER2 degradation. Creation of this phosphodegron is regulated by a phosphoswitch that is also implicated in temperature compensation. However, in vivo evidence that this phosphodegron influences circadian period is lacking. Here, we generated and analyzed PER2-Ser478Ala knock-in mice. The mice showed longer circadian period in behavioral analysis. Molecularly, mutant PER2 protein accumulated in both the nucleus and cytoplasm of the mouse liver, while Per2 messenger RNA (mRNA) levels were minimally affected. Nuclear PER1, CRY1, and CRY2 proteins also increased, probably due to stabilization of PER2-containing complexes. In mouse embryonic fibroblasts derived from PER2-Ser478Ala::LUC mice, three-phase decay and temperature compensation of the circadian period was perturbed. These data provide direct in vivo evidence for the importance of phosphorylation-regulated PER2 stability in the circadian clock and validate the phosphoswitch in a mouse model. Significance The speed of the circadian clock is regulated by phosphorylation-regulated degradation of the PER protein. However, this model has recently been challenged by genetic studies in mice and fungi. Here, we provide definitive genetic and biochemical evidence that strongly supports the importance of the phosphoswitch-regulated proteolysis of PER2 in regulating the clock. We generated two independent mouse lines with a point mutation in a casein kinase 1-dependent phosphodegron in PER2. These mice have longer circadian rhythms, increased accumulation of circadian proteins, and perturbed temperature compensation. The findings strongly support the phosphoswitch model of regulated PER2 degradation as a central mechanism controlling the speed of the circadian clock.

23 April 2024 in Nature Cancer
Verified
Journal Article
Closed access
PDF file
YWYu Wang
Yu Wang
RNRajesh Narasimamurthy
Rajesh Narasimamurthy
MQMeng Qu
Meng Qu
NSNuolin Shi
Nuolin Shi
HGHai-dong Guo
Hai-dong Guo
Nick BarkerNick Barker
Nick Barker

2 October 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
RHRachel L. Harold
Rachel L. Harold
NTNikhil Tulsian
Nikhil Tulsian
RNRajesh Narasimamurthy
Rajesh Narasimamurthy
NYNoelle Yaitanes
Noelle Yaitanes
MHMaria G. Ayala Hernandez
Maria G. Ayala Hernandez
CPCarrie L. Partch
Carrie L. Partch
Casein kinase 1δ (CK1δ) controls essential biological processes including circadian rhythms and wingless-related integration site (Wnt) signaling, but how its activity is regulated is not well understood. CK1δ is inhibited by autophosphorylation of its intrinsically disordered C-terminal tail. Two CK1 splice variants, δ1 and δ2, are known to have very different effects on circadian rhythms. These variants differ only in the last 16 residues of the tail, referred to as the extreme C termini (XCT), but with marked changes in potential phosphorylation sites. Here, we test whether the XCT of these variants have different effects in autoinhibition of the kinase. Using NMR and hydrogen/deuterium exchange mass spectrometry, we show that the δ1 XCT is preferentially phosphorylated by the kinase and the δ1 tail makes more extensive interactions across the kinase domain. Mutation of δ1-specific XCT phosphorylation sites increases kinase activity both in vitro and in cells and leads to changes in the circadian period, similar to what is reported in vivo. Mechanistically, loss of the phosphorylation sites in XCT disrupts tail interaction with the kinase domain. δ1 autoinhibition relies on conserved anion-binding sites around the CK1 active site, demonstrating a common mode of product inhibition of CK1δ. These findings demonstrate how a phosphorylation cycle controls the activity of this essential kinase.

8 May 2024 in Nature Cancer
Verified
Journal Article
Closed access
PDF file
YWYu Wang
Yu Wang
RNRajesh Narasimamurthy
Rajesh Narasimamurthy
MQMeng Qu
Meng Qu
NSNuolin Shi
Nuolin Shi
HGHai-dong Guo
Hai-dong Guo
Nick BarkerNick Barker
Nick Barker